Thermo Fisher soars in Q4; Vycor launches Class I recall of brain surgery device;

 @FierceMedDev: Startup brings molecular diagnostics to India's swelling market. Article | Follow @FierceMedDev

 @MarkHFierce: Today's Dx Extra: Another company will take on development of an RA Dx. Story | Follow @MarkHFierce

 @DamianFierce: After a weak Q4, Zimmer's counting on restructuring to save 2013 profits. News | Follow @DamianFierce

> Thermo Fisher ($TMO) posted a record $3.26 billion in fourth-quarter revenue, a 6% jump over the same period in 2011. Results

> Vycor Medical has launched a Class I recall of some of its Viewsite brain access devices, warning of serious adverse events including death. More

> California's Velomedix has enrolled the first patient in a trial of its device that works to cool the peritoneal cavity during myocardial infarction procedures. Release

> As more and more cancer drugs come paired with companion diagnostics, Dx companies are cashing in and advancing the field. Article

> Arteriocyte got the FDA's sign-off to launch a trial of its Magellan device to treat thermal burn wounds. Item

Biotech News

 @FierceBiotech: Celsion shares routed after PhIII liver cancer study flops. News | Follow @FierceBiotech

@JohnCFierce: AstraZeneca's Soriot is going to have to do something bold, something dramatic, and something a little loony. In that order. | Follow @JohnCFierce

@RyanMFierce: Holland's health minister is sounding very German on drug pricing, wants to chop cost of Genzyme and Shire therapies. More | Follow @RyanMFierce

> Venture firm preps $100M fund for late-stage life sciences investments. News

> Vanda slides after drug fails PhII/III for depression. Item

> Is AstraZeneca getting ready to buy a pipeline? Report

> Pharmaxis suffers FDA committee upset, nabs up to $40M in financing. Article

> Genentech flashes PhIII progress for prized Rituxan successor. Story

Pharma News

@FiercePharma: EMA sounds a bit perturbed about France's suspension of Diane-35. But it will review data when France asks. More | Follow @FiercePharma

 @AlisonBFierce: Life Technologies established an international flu network to develop a speedy monitoring system and better vaccine. News | Follow @AlisonBFierce

@EricPFierce: BASF says it has finally gotten the Pronova deal closed making it one of the largest fish oil producers in the world. Release | Follow @EricPFierce

> Novo meets 'sky-high' expectations with 18% sales growth. Report

> Genzyme's $176K Kynamro price undercuts its $250K-plus rival. Article

> Patent Cliff II: Nightmare on blockbuster street returns in 2015. News

Vaccines News

> MIT explores DNA vaccine delivery. Item

> Life establishes international flu network. More

> CDC: Adult vaccination rates 'unacceptably low.' Report

> FDA expands use of Pfizer's Prevnar 13. Article

> GSK, Biological E partner on childhood vaccine. Story

Pharma Manufacturing News

> Cargo theft up dramatically in Mexico. Item

> Sanofi's Genzyme looking hard at continuous manufacturing. News

> Biogen, Merck, Novartis, others have plants recognized for innovations. More

> Teva, P&G start on OTC plant in India. Story

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.